Coherus BioSciences Inc (NASDAQ:CHRS)

9.55
Delayed Data
As of 4:00pm ET
 +0.40 / +4.37%
Today’s Change
8.05
Today|||52-Week Range
26.55
+8.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.8M31.1M30.0M190.1M
 
 
 
 
 
Depreciation And Amortization404.0K674.0K1.9M3.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses38.3M95.0M246.9M303.0M
 
 
 
 
 
Research And Development31.3M78.2M212.7M254.4M
 
 
 
 
 
Total Operating Expenses38.7M95.7M248.7M306.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.0M-64.5M-218.7M-115.9M
 
 
 
 
 
Extraordinary Credit--2.0M0.000.00
 
 
Extraordinary Charge---21.2M-5.0M-4.3M
 
 
 
 
Interest Expense On Debt5.3M3.8M33.0K8.0M
 
 
 
 
 
Other Expenses-12.3M377.0K-239.0K428.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-53.6M-87.2M-223.9M-127.8M
 
 
 
 
 
Minority Interest0.00-44.0K-678.0K-451.0K
 
 
 
 
Net Income-53.6M-87.1M-223.3M-127.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.1M8.2M37.1M41.9M
 
 
 
 
 
Shares To Calculate EPS Diluted32.1M8.2M37.1M41.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.67-$10.64-$6.01-$3.04
 
 
 
 
 
EPS Diluted-$1.67-$10.64-$6.01-$3.04